Epizyme is a global biopharmaceutical company based in Cambridge, MA, dedicated to improving patients' lives through research, innovation, and the development of transformative medicines in Oncology, Rare Disease, and Neuroscience. With a focus on areas of high unmet medical need, Epizyme is accelerating its momentum and rapidly expanding its pipeline to bring the full potential of its innovative medicines to patients.
Guided by patient outcomes and supported by a culture of collaboration and excellence, Epizyme leverages its global reach and R&D firepower to partner with like-minded innovators and develop the next generation of medicines. With a strong track record in commercializing its medicines and a commitment to making a real impact for people living with high unmet medical needs, Epizyme is a leader in its field, leveraging its infrastructure, innovation, and passion to develop new therapies and valuable collaborations.
Generated from the website